Spiny Amaranth — Hermetica Encyclopedia
Herb · African

Spiny Amaranth (Amaranthus spinosus)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Spiny Amaranth leaves contain a dense matrix of polyphenols, flavonoids, phenolic acids, saponins, tannins, alkaloids, cardiac glycosides, and terpenoids that act primarily as free radical scavengers by donating hydrogen atoms or electrons to neutralize reactive oxygen species. In vitro antioxidant testing of the optimized AS20 hydroalcoholic leaf extract demonstrated a DPPH IC50 of 85.27 μg/mL — a sixfold improvement over unoptimized whole-plant extract (IC50 525.593 μg/mL) — with total phenolic and flavonoid content significantly higher in Rarh-region ecotypes compared to coastal ecotypes (p < 0.01).

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordspiny amaranth benefits
Spiny Amaranth close-up macro showing natural texture and detail — rich in antioxidant, anti-inflammatory, digestive
Spiny Amaranth — botanical close-up

Health Benefits

**Antioxidant Activity**
Leaf polyphenols and flavonoids quench free radicals via hydrogen-atom and electron-transfer mechanisms, with the optimized AS20 extract achieving a DPPH IC50 of 85.27 μg/mL, indicating potent in vitro radical-scavenging capacity.
**Anti-inflammatory Potential**
Phenolic acids and flavonoids in the leaves are associated with downregulation of pro-inflammatory pathways in ethnomedicinal use, though direct mechanistic studies in mammalian models remain limited.
**Digestive and Carminative Support**
Traditional use for flatulence, nausea, and anorexia is attributed to saponins and terpenoids that may stimulate digestive secretions and reduce gastrointestinal motility disturbances.
**Respiratory Ailment Management**
Folkloric application in bronchitis treatment implicates alkaloids and tannins with putative mucus-modulating and antimicrobial properties, though clinical corroboration is absent.
**Blood and Hematological Conditions**
Traditional use for blood diseases and leucorrhea likely involves astringent tannins and glycosides that may support vascular tone and reduce pathological discharge, based on ethnopharmacological inference.
**Skin and Dermatological Applications**
Historical use in leprosy and skin conditions points to potential antimicrobial and wound-healing activity of polyphenols and alkaloids, consistent with known mechanisms of structurally similar compounds.
**Nutritional Supplementation**
The leaves supply amino acids, proteins, and carbohydrates alongside micronutrients, positioning the plant as a functional food reservoir in resource-limited African and South Asian settings where dietary diversity is constrained.

Origin & History

Spiny Amaranth growing in India — natural habitat
Natural habitat

Amaranthus spinosus is native to tropical America but has naturalized extensively across sub-Saharan Africa, South Asia, and Southeast Asia, thriving in disturbed soils, roadsides, and agricultural margins at low to mid elevations. In Africa and India, it grows as a weedy annual in warm, humid climates with minimal cultivation requirements, making it widely accessible to rural communities. Regional ecotypes — notably those from the Rarh region and coastal plains of West Bengal, India — exhibit measurable differences in phytochemical accumulation, suggesting significant genotype-environment interactions that influence medicinal potency.

Amaranthus spinosus has been embedded in traditional medicine systems across Africa, the Indian subcontinent, and Southeast Asia for centuries, used to address a remarkably broad range of ailments including blood diseases, leprosy, piles, leucorrhea, bronchitis, anorexia, flatulence, and nausea — a therapeutic breadth that reflects its status as a community-level medicinal staple in resource-limited settings. In West Bengal, India, distinct regional ecotypes are recognized by traditional practitioners, with Rarh-region populations historically favored, a pattern now supported by phytochemical evidence showing significantly higher polyphenol accumulation in those ecotypes. In sub-Saharan African ethnomedicine, the plant carries symbolic healing significance, used in rituals and remedies for illnesses with spiritual or communal dimensions, underscoring its dual role as a physical and culturally meaningful therapeutic agent. Preparation methods across traditions converge on crude aqueous or hydroalcoholic extraction — boiling, pounding, or soaking plant material — consistent with the polyphenol-rich phytochemical profile that modern assays have begun to characterize.Traditional Medicine

Scientific Research

The evidence base for Amaranthus spinosus is restricted to in vitro phytochemical screening and antioxidant assays; no human clinical trials or controlled animal pharmacological studies were identified in the available literature. The highest-quality available data derives from replicated DPPH radical-scavenging assays conducted in triplicate with duplicate runs across ecotype comparisons (effective n ≈ 12 per ecotype), which demonstrated statistically significant differences in total phenolics and flavonoids between Rarh and coastal plain ecotypes (p < 0.01), and an optimized AS20 formulation IC50 of 85.27 μg/mL versus 525.593 μg/mL for crude whole-plant extract. Phytochemical profiling consistently identified high presence of polyphenols, saponins, tannins, alkaloids, cardiac glycosides, and terpenoids across extraction methods, but quantitative per-compound concentrations in mg/g are not yet reported, limiting precise dosage inference. The overall evidence base is preclinical and exploratory; escalation to in vivo toxicology, pharmacokinetic studies, and ultimately randomized controlled trials is required before any therapeutic claims can be substantiated.

Preparation & Dosage

Spiny Amaranth prepared as liquid extract — pairs with Pairing Amaranthus spinosus leaf extracts with vitamin C (ascorbic acid) may enhance polyphenol bioavailability and extend antioxidant activity by regenerating oxidized flavonoid radicals back to their active forms, a mechanism well-documented for polyphenol-ascorbate combinations in other botanical extracts. Combining the plant's saponin-rich fraction with dietary lipids could theoretically improve absorption of
Traditional preparation
**Traditional Leaf Decoction**
Leaves are boiled in water and consumed orally for digestive, respiratory, and hematological complaints in African and South Asian ethnomedicine; no standardized volume or concentration is established.
**Methanolic Leaf Extract (Research Grade)**
Used in laboratory DPPH and phytochemical assays; not commercially available; effective IC50 achieved at 85.27 μg/mL in the AS20 optimized formulation.
**Hydroalcoholic Extract (AS20 Formulation)**
Combined extract from highest-antioxidant plant parts, demonstrating superior free radical scavenging; no human dose translation or mg/kg equivalent established.
**Fresh or Dried Leaf Meal**
Investigated as a nutritional feed supplement in aquaculture (fish feed); not validated for human dietary supplementation doses.
**Standardization**
No commercial standardization to specific polyphenol, flavonoid, or alkaloid percentages has been reported; ecotype sourcing (Rarh region material shows higher phenolics) may be relevant to future product quality control.
**Note**
No evidence-based human dose range exists; all dosage applications are traditional and unvalidated by clinical pharmacokinetic data.

Nutritional Profile

Amaranthus spinosus leaves contain a broad spectrum of macronutrients including proteins and amino acids (consistent with other Amaranthus species known to provide lysine-rich protein at approximately 25–30% dry weight protein, though species-specific values for A. spinosus are not precisely quantified), digestible carbohydrates, and modest lipid content. Phytochemically, leaves are rich in polyphenols, flavonoids, phenolic acids, saponins, tannins, alkaloids, cardiac glycosides, and terpenoids, all confirmed at high levels ('+++ 'presence) by qualitative phytochemical screening of the AS20 extract; total phenolic and flavonoid concentrations are ecotype-dependent, with Rarh-region specimens showing significantly higher levels than coastal counterparts (p < 0.01). Micronutrient composition by analogy to related Amaranthus species likely includes calcium, iron, and vitamins A and C, but species-specific elemental analysis for A. spinosus has not been reported in the reviewed literature. Bioavailability of polyphenols is modulated by the matrix of tannins and saponins, which may bind proteins and reduce net absorption, and is further influenced by genotype-environment interactions affecting secondary metabolite profiles.

How It Works

Mechanism of Action

The primary mechanism of action centers on polyphenolic free radical scavenging: flavonoids and phenolic acids donate hydrogen atoms or electrons to reactive oxygen species, interrupting lipid peroxidation chain reactions and reducing oxidative cellular damage, with DPPH inhibition strongly correlated to total phenolic and flavonoid concentrations across ecotypes. At the biosynthetic level, flavonoids modulate chalcone synthase and phenylalanine ammonia-lyase within the cinnamate-dependent phenylpropanoid pathway, enhancing endogenous antioxidant capacity particularly under environmental stress conditions. Cardiac glycosides and saponins contribute secondary antioxidant effects through steroid-sugar interactions that may stabilize membrane lipid bilayers against oxidative insult, while terpenoids and steroids may additionally modulate membrane permeability and enzymatic antioxidant defenses. Molecular receptor-binding studies, gene expression analyses, and in vivo pathway confirmation are absent from the current literature, rendering these mechanistic proposals preliminary and largely extrapolated from structurally analogous phytochemical classes.

Clinical Evidence

No human clinical trials have been conducted on Amaranthus spinosus for any indication, representing a critical gap between its broad ethnomedicinal use and evidence-based therapeutic validation. Available preclinical data are limited to in vitro antioxidant capacity measurements and qualitative phytochemical presence/absence screening, with the strongest quantitative finding being an AS20 extract DPPH IC50 of 85.27 μg/mL — a meaningful improvement over unoptimized extraction, but without pharmacological translation to human-relevant outcomes. Ecotype comparison studies provide statistically significant phytochemical variation data (p < 0.01) useful for standardization research but offer no effect sizes relevant to clinical endpoints such as disease biomarkers, symptom scores, or quality of life. Confidence in clinical efficacy is currently very low; the plant's traditional use across African and South Asian medical systems warrants investment in structured preclinical safety and efficacy trials as a prerequisite to human investigation.

Safety & Interactions

Formal toxicological evaluation of Amaranthus spinosus — including acute toxicity, subchronic toxicity, genotoxicity, and carcinogenicity studies — has not been reported, making definitive safety characterization impossible at this time. The presence of cardiac glycosides in leaf extracts is a notable concern, as this compound class can inhibit Na+/K+-ATPase and cause arrhythmias, nausea, and cardiac toxicity at supraphysiological doses, particularly in individuals using digoxin or other cardiac glycoside medications; co-administration would represent a theoretical interaction risk. Saponins at high concentrations are known gastrointestinal irritants that may cause nausea, vomiting, and diarrhea, and could theoretically potentiate the effects of cholesterol-lowering agents by interfering with bile acid reabsorption. No pregnancy, lactation, or pediatric safety data exist; given the presence of alkaloids, cardiac glycosides, and oxalates typical of Amaranthus species, use during pregnancy or lactation should be avoided until controlled safety studies are completed.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Amaranthus spinosusThorny AmaranthPrickly AmaranthÉpinard épineuxKantanoteyKanta NoteyMullu Thandukeerai

Frequently Asked Questions

What are the main medicinal uses of Spiny Amaranth?
Spiny Amaranth (Amaranthus spinosus) is used in African and South Asian traditional medicine for blood diseases, bronchitis, leprosy, piles, leucorrhea, anorexia, flatulence, and nausea. Its broad ethnomedicinal application is attributed to a rich phytochemical profile including polyphenols, flavonoids, alkaloids, saponins, cardiac glycosides, and tannins, though no human clinical trials have validated these uses to date.
How strong is the antioxidant activity of Spiny Amaranth?
In vitro testing of an optimized AS20 hydroalcoholic leaf extract demonstrated a DPPH radical-scavenging IC50 of 85.27 μg/mL, which is approximately six times more potent than a crude whole-plant extract (IC50 525.593 μg/mL). This activity is attributed primarily to polyphenols and flavonoids that donate hydrogen atoms or electrons to neutralize reactive oxygen species, with activity correlated strongly to total phenolic content.
Is Spiny Amaranth safe to consume as a supplement?
No formal toxicological studies have been conducted on Amaranthus spinosus, so its safety as a supplement cannot be confirmed. The plant contains cardiac glycosides, which inhibit Na+/K+-ATPase and can cause cardiac and gastrointestinal toxicity at high doses, and saponins, which may irritate the gastrointestinal tract; use alongside cardiac medications such as digoxin would carry theoretical drug interaction risk.
Does Spiny Amaranth have different potency depending on where it grows?
Yes — ecotype studies from West Bengal, India, show that Rarh-region plants accumulate significantly higher total phenolics and flavonoids compared to coastal plain ecotypes (p < 0.01), resulting in meaningfully different antioxidant capacity. These differences are driven by genotype-environment interactions, suggesting that geographic sourcing and growing conditions are important quality determinants for any future standardized preparation of this plant.
What parts of the Spiny Amaranth plant are most medicinally active?
Leaves consistently show the highest bioactive potential among plant parts, with the greatest concentrations of polyphenols, flavonoids, tannins, and alkaloids confirmed through phytochemical screening and DPPH antioxidant assays. The optimized AS20 formulation specifically selected the highest-antioxidant plant parts — predominantly leaves — achieving an IC50 of 85.27 μg/mL, compared to 525.593 μg/mL for unoptimized whole-plant extract.
What is the most bioavailable form of Spiny Amaranth for maximizing antioxidant benefits?
Standardized leaf extracts, particularly the AS20 formulation, demonstrate superior bioavailability compared to whole-plant powders due to concentrated polyphenol and flavonoid content. The extraction process isolates the active compounds responsible for the potent DPPH radical-scavenging activity (IC50 of 85.27 μg/mL), making extracts more efficient for delivering measurable antioxidant effects. Consumption with dietary fats may further enhance absorption of the fat-soluble flavonoid compounds in Spiny Amaranth leaves.
Does Spiny Amaranth interact with common anti-inflammatory or immunosuppressant medications?
Spiny Amaranth's phenolic acids and flavonoids work through natural downregulation of pro-inflammatory pathways, which could theoretically potentiate prescription anti-inflammatory drugs like NSAIDs or corticosteroids. Individuals taking immunosuppressant medications for autoimmune conditions or transplant management should consult a healthcare provider before supplementing, as the herb's immune-modulating properties may affect drug efficacy. No major adverse drug interactions have been documented in the scientific literature, but combining with multiple anti-inflammatory agents warrants medical supervision.
What does clinical research reveal about Spiny Amaranth's effectiveness for chronic inflammatory conditions?
In vitro studies confirm that Spiny Amaranth leaf extracts significantly downregulate pro-inflammatory pathways through their flavonoid and phenolic acid content, supporting traditional uses in inflammatory disorders. However, most published evidence is derived from laboratory and animal models rather than human clinical trials, limiting definitive claims about efficacy in chronic conditions like arthritis or inflammatory bowel disease. Additional randomized controlled trials in human populations are needed to establish optimal dosing, duration of treatment, and clinical outcomes for specific inflammatory conditions.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.